Global Longlife Hospital and Research Ltd.

GLHRL

Market Cap
₹34 Cr.
P/E
0.00

Global Longlife Hospital and Research Ltd.

About
Global Longlife Hospital and Research Limited is a healthcare company that provides a wide range of services including Oncology, Ophthalmology, Cardiology, Dermatology, and Physiotherapy. The company … Read more
Global Longlife Hospital and Research Limited is a healthcare company that provides a wide ran… Read more
Low
27
52W Range
High
62
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

2 No Data

Insufficient data to analyse

ROE
Latest
2.84%
3yr Average
12.96%
5yr Average
8.48%
Net Profit Margin
Latest
7.78%
3yr Average
8.31%
5yr Average
5.26%
ROCE
Latest
4.76%
3yr Average
21.56%
5yr Average
17.53%
Debt to Equity
Latest
0.14
3yr Average
0.63
5yr Average
1.23
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison
FAQs on Global Longlife Hospital and Research Ltd. Business

Global Longlife Hospital provides a range of healthcare services including oncology, cardiology, and surgery. It is certified by NABH and has invested in an IT system for clinical and administrative functions.

Global Longlife Hosp major competitors are Family Care Hospital, Tejnaksh Healthcare, Fortis MalarHospital, Aashka Hospitals, KMC Speciality Hosp, Dr Agarwals Eye Hsp, Indraprastha Medical.
Market Cap of Global Longlife Hosp is ₹34 Crs.
While the median market cap of its peers are ₹271 Crs.

Global Longlife Hosp seems to be less financially stable compared to its peers.
Altman Z score of Global Longlife Hosp is 4.0 and is ranked 7 out of its 8 competitors.

Company Filing
2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Discussions & Analysis
timeline Timeline